The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
What Does Index Level Tell Us summarizes the core takeaways from index readings, offering a straightforward lens to interpret trends and potential moves.
19,344 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Analysts watch Verrica's 2026 earnings for clues on VP-102 sales, cash runway, and pipeline progress. This guide brea...
Investors are shifting capital away from Tesla toward SpaceX and AI-driven platforms, reshaping how the market values...
A troubling scam shows how families paid $12K Italy for a soccer camp that vanished. This guide breaks down warning s...
A practical look at Farmland Partners (FPI) earnings and what they mean for investors. We break down the numbers, tre...
A small stake in a leading solar company sparked big learning for investors. This million solar lands move shows how ...
CoreWeave's stock has fallen sharply in May as costs rise and guidance disappoints. This guide breaks down the reason...
A dramatic 1034% rally can lure buyers, but momentum alone doesn’t ensure value. This guide breaks down how to assess...
As memory chip inventories weigh on the tech sector, the Dow shows remarkable resilience. This article breaks down wh...
Bridger Management quietly exited a large Bath & Body Works position in the fourth quarter, selling about 301,000 sha...
CoreWeave stock gets headlines can spark investor interest, but smart portfolios look beyond headlines. This guide ex...
A Taboola director disclosed a sizable open-market sale of 61,000 shares. This article explains what insider trades c...